Pridopidine placebo
Sponsors
Ferrer Internacional S.A., Prilenia Therapeutics B.V.
Conditions
Amyotrophic Lateral SclerosisHuntington’s disease (HD).
Phase 3
A Phase 3, Randomized, Double-blind, Placebo-controlled Study to Evaluate the Efficacy and Safety of Pridopidine in Participants with Amyotrophic Lateral Sclerosis
Not yet recruitingCTIS2025-524002-16-00
Target: 133Updated: 2026-04-20
A Phase 3, Randomized, Double-blind, Placebo-controlled Study to Evaluate the Efficacy and Safety of Pridopidine in Participants with Huntington’s disease (HD).
Not yet recruitingCTIS2026-526093-16-00
Target: 62Updated: 2026-10-13